טוען...
Pharmacological Properties of DOV 315,090, an ocinaplon metabolite
BACKGROUND: Compounds targeting the benzodiazepine binding site of the GABA(A)-R are widely prescribed for the treatment of anxiety disorders, epilepsy, and insomnia as well as for pre-anesthetic sedation and muscle relaxation. It has been hypothesized that these various pharmacological effects are...
שמור ב:
| Main Authors: | , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2008
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2529273/ https://ncbi.nlm.nih.gov/pubmed/18554397 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2210-8-11 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|